# Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine

> **NCT01815073** · PHASE4 · COMPLETED · sponsor: **Changchun Keygen Biological Products Co., Ltd.** · enrollment: 497 (actual)

## Conditions studied

- Japanese Encephalitis
- Chickenpox

## Interventions

- **BIOLOGICAL:** Live Attenuated Varicella Vaccine + Live Attenuated JE Vaccine
- **BIOLOGICAL:** Live Attenuated Varicella Vaccine
- **BIOLOGICAL:** live attenuated JE vaccine

## Key facts

- **NCT ID:** NCT01815073
- **Lead sponsor:** Changchun Keygen Biological Products Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 497 (ACTUAL)
- **Last updated:** 2014-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01815073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01815073, "Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT01815073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*